163 related articles for article (PubMed ID: 11420469)
1. Atypical bile duct adenoma, clear cell type: a previously undescribed tumor of the liver.
Albores-Saavedra J; Hoang MP; Murakata LA; Sinkre P; Yaziji H
Am J Surg Pathol; 2001 Jul; 25(7):956-60. PubMed ID: 11420469
[TBL] [Abstract][Full Text] [Related]
2. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
[TBL] [Abstract][Full Text] [Related]
3. Bile duct adenoma may be a precursor lesion of small duct type intrahepatic cholangiocarcinoma.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2021 Jan; 78(2):310-320. PubMed ID: 33405289
[TBL] [Abstract][Full Text] [Related]
4. Cholangiocarcinoma arising in bile duct adenoma with focal area of bile duct hamartoma.
Hasebe T; Sakamoto M; Mukai K; Kawano N; Konishi M; Ryu M; Fukamachi S; Hirohashi S
Virchows Arch; 1995; 426(2):209-13. PubMed ID: 7757293
[TBL] [Abstract][Full Text] [Related]
5. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma.
Xiao SY; Wang HL; Hart J; Fleming D; Beard MR
Am J Pathol; 2001 Oct; 159(4):1415-21. PubMed ID: 11583969
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemistry in the differential diagnosis of liver carcinomas.
Hurlimann J; Gardiol D
Am J Surg Pathol; 1991 Mar; 15(3):280-8. PubMed ID: 1847609
[TBL] [Abstract][Full Text] [Related]
7. Cholangiocarcinoma associated with multiple bile-duct hamartomas of the liver.
Dekker A; Ten Kate FJ; Terpstra OT
Dig Dis Sci; 1989 Jun; 34(6):952-8. PubMed ID: 2470558
[TBL] [Abstract][Full Text] [Related]
8. Intrahepatic clear cell cholangiocarcinoma: immunohistochemical aspects in a very rare type of cholangiocarcinoma.
Haas S; Gütgemann I; Wolff M; Fischer HP
Am J Surg Pathol; 2007 Jun; 31(6):902-6. PubMed ID: 17527078
[TBL] [Abstract][Full Text] [Related]
9. An immunohistochemical study of hepatic atypical adenomatous hyperplasia, hepatocellular carcinoma, and cholangiocarcinoma with alpha-fetoprotein, carcinoembryonic antigen, CA19-9, epithelial membrane antigen, and cytokeratins 18 and 19.
Tsuji M; Kashihara T; Terada N; Mori H
Pathol Int; 1999 Apr; 49(4):310-7. PubMed ID: 10365850
[TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of biliary tract lesions.
Tan G; Yilmaz A; De Young BR; Behling C; Lehman A; Frankel WL
Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):193-7. PubMed ID: 15551730
[TBL] [Abstract][Full Text] [Related]
12. Bile duct adenoma and small-sized small duct type intrahepatic cholangiocarcinoma show distinct differences in genetic alterations, expression of IMP3 and EZH2 and stromal and inflammatory components.
Sasaki M; Sato Y; Nakanuma Y
Histopathology; 2023 Aug; 83(2):298-309. PubMed ID: 37140546
[TBL] [Abstract][Full Text] [Related]
13. Bile duct adenomas with endocrine component. Immunohistochemical study and comparison with conventional bile duct adenomas.
O'Hara BJ; McCue PA; Miettinen M
Am J Surg Pathol; 1992 Jan; 16(1):21-5. PubMed ID: 1370191
[TBL] [Abstract][Full Text] [Related]
14. Clear cell carcinomas of the gallbladder and extrahepatic bile ducts.
Vardaman C; Albores-Saavedra J
Am J Surg Pathol; 1995 Jan; 19(1):91-9. PubMed ID: 7802141
[TBL] [Abstract][Full Text] [Related]
15. Distinction between hepatocellular carcinoma, cholangiocarcinoma, and metastatic carcinoma based on immunohistochemical staining for carcinoembryonic antigen and for cytokeratin 19 on paraffin sections.
Balaton AJ; Nehama-Sibony M; Gotheil C; Callard P; Baviera EE
J Pathol; 1988 Dec; 156(4):305-10. PubMed ID: 2465399
[TBL] [Abstract][Full Text] [Related]
16. [Combined hepatocellular-cholangiocarcinoma (cholangiolocellular type) with stem-cell features: a clinicopathologic analysis of 26 cases].
Xu J; Zhang C; Qiao A; Xi Y
Zhonghua Bing Li Xue Za Zhi; 2016 Mar; 45(3):175-9. PubMed ID: 26956962
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic diversity of intrahepatic and extrahepatic cholangiocarcinoma on aspiration cytology and core needle biopsy: case series and review of the literature.
Chaudhary HB; Bhanot P; Logroño R
Cancer; 2005 Aug; 105(4):220-8. PubMed ID: 15952192
[TBL] [Abstract][Full Text] [Related]
18. Well-differentiated adenocarcinoma, gastric foveolar type, of the extrahepatic bile ducts: A previously unrecognized and distinctive morphologic variant of bile duct carcinoma.
Albores-Saavedra J; Delgado R; Henson DE
Ann Diagn Pathol; 1999 Apr; 3(2):75-80. PubMed ID: 10196386
[TBL] [Abstract][Full Text] [Related]
19. Rapidly growing mucinous cholangiocarcinoma.
Motoo Y; Sawabu N; Minamoto T; Kawakami H; Ohta H; Okai T; Fujimoto T; Mai M; Matsui O; Nakanishi I
Intern Med; 1993 Feb; 32(2):116-21. PubMed ID: 8389623
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical profile of the so-called bile duct adenoma: clues to pathogenesis.
Hughes NR; Goodman ZD; Bhathal PS
Am J Surg Pathol; 2010 Sep; 34(9):1312-8. PubMed ID: 20679879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
